Optimization of conditions for in vitro threedimensional cartilage growth by Mihaela Jagrić et al.
71
Rad 526. Medical Sciences, 43(2016) : 53-73
3rd International Conference on Regenerative Orthopaedics 4 November 2015, Zagreb, Croatia 
lity with NSCs and their cell labeling efficiency in vitro when compared to both 
their uncoated γ-Fe2O3 counterparts and commercially available dextran-coated 
nanomag®-D-spio nanoparticles. Finally, we used poly(L-lysine)-γ-Fe2O3 and 
(D-mannose)-γ-Fe2O3 nanoparticles to label NSCs which were transplanted into 
mouse post-ischemic brain and tracked during brain repair using magnetic reso-
nance. Both poly(L-lysine)-γ-Fe2O3 and (D-mannose)-γ-Fe2O3 could easily be vi-
sualized in ex vivo mouse post-ischemic brain, making them an attractive agent for 
future NSC in vivo tracking studies. 
GlowBrain here presents a platform which allows in vitro and in vivo investi-
gation of biocompatibility of biomaterials that can serve as support for NSCs, ulti-
mately allowing their survival and differentiation in post-ischemic brain. Moreover, 
our platform can be used to assay in vitro the effects of labeling NSCs with diffe-
rently coated γ-Fe2O3 nanoparticles, namely cell viability and proliferation, cellular 
uptake efficiency and labeling mechanism as well as potential to be visualized in 
vivo in mouse ischemic brain. 
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Articular cartilage is a poorly vascularized and innervated tissue that shows no 
capacity for effective spontaneous regeneration in cases of damage and injury, whi-
ch represents a major health problem and unmet medical need. Common methods 
of the treatment and therapy have proved to be ineffective. Tissue engineering, as a 
new important field of regenerative medicine, emerges as potential effective alter-
native. Chondrogenesis, the process by which cartilage is formed, actually repre-
sents the consequence of several steps directed by signaling molecules, receptors, 
transcription factors, cells’ interaction with ECM and other environmental factors. 
In this respect, the aim of our study was to optimize conditions for 3D in vitro chon-
drogenesis in order to produce functional cartilage implants that could be used in 
clinical practice to cure some specific cartilage defects. 
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The method of optimization includes: i) cell type; ii) source of dexamethasone; 
and iii) percentage of oxygen. In the experiment three different cell culture types 
were used: chondrocytes, human mesenchymal stem cells from bone marrow 
(hMSC) and combination of chondrocytes and hMSC in 2:1 ratio. Cells were grown 
in 3D culture, incorporated in a peptide hydrogel RADA (BD PuraMatrix Peptide 
Hydrogel). In order to induce chondrogenesis, cells were put in a differentiation me-
dium containing ascorbic acid-2-phosphate, L-proline, ITS, TGFβ-1 and dexametha-
sone. Dexamethasone was added in a differentiation medium or it was incorporated 
with cells within a peptide hydrogel. In order to demonstrate the effect of oxygen 
level on the efficiency of chondrogenic differentiation, cells were grown in normoxic 
(20% O2) and hypoxic conditions (5%O2). Expression levels of two important car-
tilage marker genes, SOX9 and agreccan, were evaluated by quantitative PCR in 
samples on day10 and day21 after induction of chondrogenesis. 
Our results provide important insights into effects of how different cell type, 
dexamethasone source and oxygen level affect efficiency of in vitro chondrogenesis. 
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Platelet-rich plasma (PRP) due to its role in wound healing, has spanned various 
fields of orthopaedics and sports medicine . Among athletes muscle injuries are com-
mon and may be associated with impaired functional capacity. The vulnerability of 
athletes to strains and contusions represents a substantial problem for professional 
players and their clubs. Such injuries involve significant time lost from training and 
competition. Presently there are no drugs available to hasten restoration of muscle 
function after injury and the results of healing with conventional therapy including 
rest, ice, compression, and elevation (RICE) are often inadequate. Therefore platelet-
rich plasma (PRP) therapies may help athletes by promoting muscle regeneration , 
enhancing the process of soft-tissue healing and to decrease time to recovery.PRP 
is generally considered an elective treatment for subacute and chronic conditions. 
In orthopaedics and sports medicine is used to treat tendinopathies, ligament spra-
ins, muscle strains, degenerative joint conditions. PRP is obtained from a sample 
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